Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14

Br J Dermatol. 2014 Aug;171(2):420-2. doi: 10.1111/bjd.12952. Epub 2014 Aug 6.

Authors

O Eytan¹, O Sarig, E Sprecher, M A M van Steensel

Affiliation

¹ Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, 642395, Israel; Department of Human Molecular Genetics & Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, 69978, Israel.

PMID: 24641799
DOI: 10.1111/bjd.12952

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
CARD Signaling Adaptor Proteins / genetics*
Dermatologic Agents / therapeutic use*
Guanylate Cyclase / genetics*
Humans
Male
Membrane Proteins / genetics*
Middle Aged
Mutation / genetics*
Pityriasis Rubra Pilaris / drug therapy*
Pityriasis Rubra Pilaris / genetics
Ustekinumab

Substances

Antibodies, Monoclonal, Humanized
CARD Signaling Adaptor Proteins
Dermatologic Agents
Membrane Proteins
CARD14 protein, human
Guanylate Cyclase
Ustekinumab

Supplementary concepts

Familial pityriasis rubra pilaris